BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 22 June 2007. doi:10.1136/bjsm.2007.037630
British Journal of Sports Medicine 2008;42:130-133
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjsm.2007.037630v1
42/2/130    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guidetti, L
Right arrow Articles by Baldari, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guidetti, L
Right arrow Articles by Baldari, C

ORIGINAL ARTICLES

Effect of tadalafil on anaerobic performance indices in healthy athletes

L Guidetti, G P Emerenziani, M C Gallotta, F Pigozzi, L Di Luigi, C Baldari

Department of Health Sciences, University IUSM of Rome, Italy

Correspondence to:
Professor C Baldari, Istituto Universitario di Scienze Motorie (IUSM), Piazza Lauro De Bosis, 15, 00194 Roma, Italy; carlo.baldari{at}iusm.it

Objective: Given the therapeutic and non-therapeutic use of the tadalafil, (phosphodiesterase-5 inhibitor, PDE-5i), we examined its effects on anaerobic performance indices.

Methods: In total, 12 well-trained subjects reported to the laboratory on two occasions 1 week apart to perform a 30 s Wingate anaerobic power test (WAnT) on a bicycle ergometer. The day before the WAnT, the subjects were double-blinded to receive an oral dose of tadalafil (20 mg) or placebo. Blood lactate value at rest and 1, 3, 6 and 10 minutes of recovery phase, mean power, peak power, time to peak power and fatigue index were assessed for each WAnT.

Results: Blood lactate values at the 3-min recovery WAnT increased significantly in the tadalafil condition (mean (SD) 13.9 (1.7) v 12.8 (1.3) mmol/l; p<0.05) and time to peak power decreased significantly (6.3 (1.3) v 5.7 (1.5) s; p = 0.05). No differences were observed in any other parameters between the two conditions.

Conclusion: The primary finding of this investigation was that the administration of a single dose of a long-term PDE-5i does not substantially influence anaerobic performance indices. However, results demonstrated both an increase in lactate values at the 3-min point of the recovery phase and a decrease in time to peak power.


Keywords: PDE-5i; erectile dysfunction; sport; nitric oxide




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. Di Luigi, C. Baldari, P. Sgro, G. P. Emerenziani, M. C. Gallotta, S. Bianchini, F. Romanelli, F. Pigozzi, A. Lenzi, and L. Guidetti
The Type 5 Phosphodiesterase Inhibitor Tadalafil Influences Salivary Cortisol, Testosterone, and Dehydroepiandrosterone Sulphate Responses to Maximal Exercise in Healthy Men
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3510 - 3514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine